There is crosstalk between transforming growth factor-β and interleukin-6 pathway, which contributes to the EMT of liver cancer cells and promotes the dedifferentiation of liver cancer cells so as to promote the progression of liver cancer (55). Here, IL6 is linked to liver cancer.